123

UNITE glioblastoma

Understanding and targeting resistance in glioblastoma

We aim to develop concepts to predict and monitor treatment response and failure, and ultimately, to discover novel therapies for glioblastoma patients

More about UNITE
Link to: Research
UNITE Reasearch Header Image

RESEARCH AND WORK PACKAGES

TELL ME MORE
Link to: School
UNITE School Header Image

Unite School of Neurooncology

LEARN MORE
Member Teaser Image

MEMBERS

UNITE Glioblastoma brings together physician-scientists and scientists from Heidelberg University Hospital, University Hospital Mannheim, the German Cancer Research Center and Mannheim University of Applied Sciences.

GET TO KNOW ALL MEMBERS

EVENTS

UNITE coordinates regular seminars and symposia with internal and external speakers presenting the latest research findings in glioblastoma research.

FIND OUT ABOUT CURRENT UNITE EVENTS
Event Teaser Image

Participating Institutions

More about

NEWS

All News
EANO Guideline 2

EANO GUIDELINES ON THE DIAGNOSIS AND TREATMENT OF DIFFUSE GLIOMAS OF ADULTHOOD

UNITE  towards clinical implementation In response to major changes in diagnostic algorithms and the publication of mature results from various large clinical trials, the European Association of Neuro-Oncology…
Read more
1 s2.0 S0092867420309466

ArticleIL4I1 IS A METABOLIC IMMUNE CHECKPOINT THAT ACTIVATES THE AHR AND PROMOTES TUMOR PROGRESSION

  Research findings related to UNITE work package C04 Aryl hydrocarbon receptor (AHR) activation by tryptophan (Trp) catabolites enhances tumor malignancy and suppresses anti-tumor immunity. The…
Read more
header unite goverance linesUNITE

HETEROGENEITY OF RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN HYPERMUTATED EXPERIMENTAL GLIOMAS

Research findings related to UNITE work package B01 Intrinsic malignant brain tumors, such as glioblastomas are frequently resistant to immune checkpoint blockade (ICB) with few hypermutated glioblastomas…
Read more